OGEN ORAGENICS INC

NEUTRAL Impact: 4/10 EFFECT
Horizon weeks Filed Mar 23, 2026 Processed 1mo ago SEC 9999999995-26-000882
IPO/offering going effective
Latest settled — T+20d
OGEN ▼ -2.94% at T+20d
NEUTRAL call ✗ call lost -2.94% · α vs SPY -10.36% · entry $0.6800 → $0.6600
Next anchor: T+60d in 28d
Currently $0.5845 · -14.04% from $0.6800 entry
Entry anchored
Mar 20, 03:49 PM ET
via Databento tick
T+1d
-4.41%
call -4.41% · α -4.06%
$0.6500
settled 8w ago
T+5d
-26.47%
call -26.47% · α -22.91%
$0.5000
settled 7w ago
T+20d
-2.94%
call -2.94% · α -10.36%
$0.6600
settled 29d ago
T+60d
call — · α —
in 28d

Price Chart

Loading chart...

Executive Summary

Oragenics Inc. (OGEN) has announced the effectiveness of its shelf registration statement (Form S-3), allowing the company to issue unspecified securities from time to time. The filing became effective on March 20, 2026, enabling future capital raises.

Actionable Insight

Traders should monitor for future prospectus supplements that will disclose specific offering terms, including size, price, and use of proceeds. Given the company's small market cap, any future issuance could lead to significant dilution and downward pressure on the stock price.

Key Facts

  • Oragenics Inc. (OGEN) filed an EFFECT notice for a shelf registration on Form S-3 (File No. 333-292880).
  • The registration became effective on March 20, 2026.
  • The shelf registration allows the company to issue unspecified amounts of securities in one or more offerings.
  • No specific offering size, pricing, or use of proceeds was disclosed in this filing.
  • The company has a market cap of approximately $3M, indicating high sensitivity to potential dilution.

Financial Impact

Not specified

dilutionequity

Risk Factors

  • Potential for significant equity dilution due to the shelf registration.
  • Future offerings could be priced at a discount, negatively impacting existing shareholders.
  • Lack of transparency on offering size or timing creates uncertainty.

Market Snapshot

Exchange
NYSE

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000882
Document: 9999999995-26-000882-index.html9999999995-26-000882
Document: 9999999995-26-000882.txt9999999995-26-000882
8 reports for OGEN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OGEN — sortable, filterable
Type Now
May 20, 2026
today
DEFA14A
NEUTRAL ★ 6/10
awaiting T+5
May 19, 2026
1d ago
8-K
NEUTRAL ★ 4/10
$0.5711 awaiting T+5awaiting T+5$0.5845 (+2.35%)
May 7, 2026
13d ago
8-K
NEUTRAL ★ 4/10
$0.6100 $0.5700▼ −6.56%▼ −8.06%$0.5845 (−4.18%)
Apr 13, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.6800 $0.7100▲ +4.41%▲ +1.12%$0.5845 (−14.04%)
Mar 25, 2026
8w ago
Press Release
BEARISH ★ 7/10
$0.5800 $0.5600▲ +3.45%▲ +5.08%$0.5845 (−0.78%)
Mar 23, 2026
8w ago
EFFECT
NEUTRAL ★ 4/10
$0.6800 $0.5000▼ −26.47%▼ −22.91%$0.5845 (−14.04%)
Mar 11, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$0.9600 $0.7500▼ −21.88%▼ −20.90%$0.5845 (−39.11%)
Mar 11, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$0.8800 $0.7900▼ −10.23%▼ −8.04%$0.5845 (−33.58%)
Showing 8 of 8

US Market Status

Market Closed — Opens Thu (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access